IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 59 filers reported holding IKENA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,262,024 | -24.7% | 1,446,195 | +14.1% | 0.00% | – |
| Q2 2023 | $8,313,770 | +684.4% | 1,267,343 | +312.5% | 0.00% | – |
| Q1 2023 | $1,059,956 | +30.5% | 307,234 | +0.6% | 0.00% | – |
| Q4 2022 | $812,406 | -54.4% | 305,416 | -39.2% | 0.00% | – |
| Q3 2022 | $1,783,000 | +39.8% | 502,152 | +74.5% | 0.00% | – |
| Q2 2022 | $1,275,000 | -86.0% | 287,748 | -80.7% | 0.00% | – |
| Q1 2022 | $9,108,000 | -46.7% | 1,493,161 | +9.5% | 0.00% | – |
| Q4 2021 | $17,102,000 | +180.0% | 1,363,877 | +181.8% | 0.00% | – |
| Q3 2021 | $6,107,000 | -3.3% | 483,931 | +7.6% | 0.00% | – |
| Q2 2021 | $6,314,000 | +156.8% | 449,738 | +416.8% | 0.00% | – |
| Q1 2021 | $2,459,000 | – | 87,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |